Author Archive
Out-of-pocket expense payment for unlicensed Cefuroxime 5% eye drops preservative free
From March 1st 2024, an additional fixed out-of-pocket expense payment of £50, will be automatically applied to NHS prescriptions for Cefuroxime 5% eye drops preservative free -a non-Drug Tariff special!...
Retrospective Top Up Payments for Concession Prices
The first list of Retrospective Top Up payments has been published in the April Drug Tariff. Every quarter, a retrospective top-up payment to the concessionary prices granted three quarters before...
UPDATE: Hormone Replacement Therapy on PPC
HRT Prescribing For PPCs – GP IT update Source: Community Pharmacy England As announced in the NHS Primary Care bulletin (published 14 March 2024), over half of GP surgeries...
Dispex Data – are you using it to its full potential?
Profitability Tools At Dispex, we pride ourselves in the quality and quantity of data we provide to dispensing doctors so that they can improve their dispensary profitability. All the relevant...
Drug Tariff Changes
Each month we publish Additions and Deletions from the Drug Tariff that affect Dispensing doctors. In addition, we sift through the Drug Changes to highlight commonly dispensed items, looking at...
The DES Specification Contract has been announced: Training Funding!!
Leadership and Management Training Funding The 2024-25 PCN DES contract specification allows for a Leadership and Management payment, but this is now combined into the core PCN Funding. Please click...
DDA Annual Conference 2024: Delegate Booking Opens 15 April 2024
The DDA Conference will once again be held at the Burlington Hotel Events Centre, Birmingham on the 25th and 26th of September 2024. There are already 34 Exhibitors booked...
Class 3 Medicines Recall: Accord-UK Ltd, Co-Codamol 8/500mg Effervescent Tablets
Class 3 Medicines Recall: Accord-UK Ltd, Co-Codamol 8/500mg Effervescent Tablets (Key Pharmaceuticals Livery), EL (24)A/12 Source: MHRA / Gov.uk 10.4.24 Accord-UK Ltd is recalling a specific batch of Co-Codamol 8/500mg...
Dispex Training Options
Dispex is considered to be the leading educational company in the UK, providing professional training, advice and consultancy which purely focuses on dispensing practices- as well as providing profitability tools...
How To Utilise Our Generics Costing More Than Tariff Tool
Watch our short video on how to utilise our member’s only tool ( you may need to scroll down)!!
NEW SOP: HRT Prescription Sorting P14
Dispex is pleased to provide its members with a SOP template library: All Templates MUST be personalised to individual practices. Scope HRT Prescription Sorting p14 This SOP applies specifically to...
Class 3 Medicines Recall: Bristol-Myers Squibb Pharmaceuticals Limited,
Source: MHRA/Gov.uk 4.4.24 Class 3 Medicines Recall: Bristol-Myers Squibb Pharmaceuticals Limited, OPDIVO 10 mg/mL concentrate for solution for infusion (nivolumab), EL(24)A/11 Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that...
